These are news releases that are related to our Investor efforts. Releases are listed in chronological order and are archived by year. Sign-up to receive news as it is released using the email and RSS tools below.
Aug 9, 2016
-- Partner Endo exercised opt-in for human lipoma indication for CCH following positive Phase 2 results; triggers $750,000 opt-in payment to BioSpecifics --
Jun 13, 2016
- Trial meets primary endpoint of an 83.4% reduction in lipoma visible surface area relative to placebo -